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INTRODUCTION
Vitamin B12 and folid acid take 
part in the erythrocytopoesis. 
As a lack of these vitamins in 
the patients bodies, 
megaloblastic anemia appear. 
In Daily transfusion hospital, during the 
last five years, 62 patients have been 
diagnosed and treated with 
megaloblastic anemia. The basic 
hematologic and biochemical analysis 
number of Er, Le, Tr, Hb, Hct, MCV, 
MCH, MCHC, indirect bilirubin, serum 
Fe, have been analysed in the Central 
biochemical laboratory. Serum LDH was 
according to the method DGKC with 
reagents by the company DiaSys, on 
the automatic analyzer COBAS MIRA 
plus.
METHODS
Elevation of lactate 
dehydrogenase (LDH) in the 
serum of patients sufferir from 
anemia together with the other 
hematologic and biochemical 
tests as an important differential 
diagnostic parametar of 
megaloblastic anemia.
PURPOSE
Although LDH is an enzyme which increases in the serum of patients suffering
from many other diseases, its dramatic elevation and dynamics in patients with
anemic syndrome are an important indicator in the diagnosis of megaloblastic
anemia. Also, the reduction of the values of LDH to their normalization helps to
monitor the efficiency of the given therapy.
CONCLUSION
The hematologic analysis 
showed reduced number of Er, 
Hb, Hct with increased values of 
MCV, MCH, MCHC. Biochemical 
analysis have shown increased 
value of the indirect bilirubin, 
serum Fe and LDH, whose 
activities ranged from 673-7745 
Ul/L (N=160-480 Ul/L). After 
receiving of the therapy of LDH 
were quickly normalized.
RESULTS
